- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01407614
The Tilburg Vasospasm Study
Prevention of Secondary Ischemia After Aneurysmal Subarachnoid Hemorrhage With Cerebrospinal Fluid Drainage. A Randomized Controlled Trial
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Delayed cerebral ischemia (DCI) is a frequent complication after an aneurysmal subarachnoid hemorrhage (SAH). Its pathophysiological mechanism remains unclear but a role for cerebral vasospasm and the presence of blood in the arachnoid space is likely. A wash out of blood and blood breakdown products in the cerebrospinal fluid (CSF) could reduce the incidence of vasospasm and DCI.
We aim to assess whether external lumbar drainage (ELD) of CSF is safe and reduces secondary ischemia and its sequelae.
Study Type
Enrollment (Actual)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
Brabant
-
Tilburg, Brabant, Netherlands, 5022 GC
- St Elisabeth Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- spontaneous subarachnoid hemorrhage (SAH) with aneurysmal pattern graded as a Fisher grade III or higher on cerebral CT-scan.
- CSF drainage by external lumbar catheter can start within 96 hours after the initial SAH
- the drainage can start prior to the treatment of the ruptured aneurysm
- informed consent is signed by the patient or his representative
Exclusion Criteria:
- spontaneous SAH with aneurysmal pattern graded as a Fisher grade I or II on CT and perimesencephalic hemorrhages
- traumatic SAH
- symptomatic hydrocephalus on admission necessitating drainage (EVD or ELD)
- the presence of a large intraventricular bloodclot in the third or fourth ventricle on CT
- the presence of a mass lesion with significant cerebral midline shift
- all patients whose neurological condition is too poor to allow clinical recognition of signs and symptoms of cerebral vasospasm. This includes all patients with a Hunt and Hess Grade V who failed to improve after initial resuscitation
- no informed consent
- mycotic aneurysms
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Single Group Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: external lumbar drainage
Within 96 hours of initial subarachnoid hemorrhage, patients were randomized for external lumbar drainage (ELD)of cerebrospinal fluid during a maximum of 7 days or standard treatment of subarachnoid hemorrhage without ELD
|
Patients were randomized for external lumbar drainage of cerebrospinal fluid or standard treatment of a subarachnoid hemorrhage alone.
External drainage was started within 96 hours of initial subarachnoid hemorrhage during 7 days at a maximum of 5-10 ml/hour.
|
No Intervention: No intervention
In this arm the patients received standard treatment following protocol for patients with subarachnoid hemorrhage
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Clinical signs of delayed cerebral ischemia
Time Frame: Patients will be followed for the duration of admission, an expected average of 3 weeks
|
DCI was diagnosed when all of the following criteria were met: (1) the onset of new neurological deficits such as confusion, disorientation, drowsiness, or focal deficit during post-hemorrhage days (4 to 14); (2) negative findings on CT obtained to rule out other causes of neurological deterioration such as hemorrhage, cerebral edema, or hydrocephalus.
(3) No other identifiable cause of neurological deterioration such as hyponatriemia, hypoxia, drug toxicity, infection, or seizures.
|
Patients will be followed for the duration of admission, an expected average of 3 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
dichotomized Glasgow outcome score (GOS)
Time Frame: at discharge, an expected average of 3 weeks after initial bleeding
|
Glasgow outcome scale was measured at discharge
|
at discharge, an expected average of 3 weeks after initial bleeding
|
new ischemic lesions on cerebral CT scan
Time Frame: at 3 months after initial bleeding
|
at 3 months after initial bleeding
|
|
length of stay in intensive care unit
Time Frame: Patients will be followed from initial admission until discharge, an expected average of 3 weeks
|
The length of stay in the intensive care unit will be measured.
|
Patients will be followed from initial admission until discharge, an expected average of 3 weeks
|
rebleeding rate of unsecured aneurysms and complications of external lumbar drainage
Time Frame: Patients willl be followed from initial bleeding until treatment of aneurysm, an expected average of 3 days
|
Evaluation of rebleeding rate of unsecured cerebral aneurysms during external lumbar drainage (ELD) of cerebrospinal fluid and evaluation of (other) complications of ELD such as (local)infection, discomfort/pain.
|
Patients willl be followed from initial bleeding until treatment of aneurysm, an expected average of 3 days
|
dichotomized Glasgow outcome score (GOS
Time Frame: at 3 months after initial bleeding
|
at 3 months after initial bleeding
|
|
clinical signs of delayed cerebral ischemia
Time Frame: At 3 months after initial bleeding
|
As stated in first primary outcome measure 'clinical signs of cerebral ischemia' during admission.
|
At 3 months after initial bleeding
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Paul Depauw, MD, Elisabeth-TweeSteden Ziekenhuis
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 15378
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Brain Ischemia
-
Centre Hospitalier Universitaire, AmiensRecruitingNeonatal Encephalopathy | Anoxia-Ischemia, BrainFrance
-
Western University, CanadaUnknownBrain Hypoxia IschemiaCanada
-
Hospital Universitario Dr. Jose E. GonzalezCompleted
-
Nagoya UniversityLife Science Institute, Inc.CompletedHypoxia-Ischemia, BrainJapan
-
Second Affiliated Hospital, School of Medicine,...Not yet recruitingHypoxia-Ischemia, BrainChina
-
Gachon University Gil Medical CenterWithdrawnCerebral Ischemia-HypoxiaKorea, Republic of
-
Washington University School of MedicineEnrolling by invitation
-
University of California, IrvineBeckman Laser Institute University of California IrvineCompletedHypoxia-Ischemia, Brain | Signs and SymptomsUnited States
-
Eunice Kennedy Shriver National Institute of Child...CompletedHypoxia, Brain | Hypoxia-Ischemia, BrainUnited States
-
Sahlgrenska University Hospital, SwedenRecruitingExtracorporeal Membrane Oxygenation | Cardiac Arrest | Hypoxia-Ischemia, BrainSweden
Clinical Trials on external lumbar drainage (ELD) of cerebrospinal fluid
-
Chang Gung Memorial HospitalUnknownBrain Injury | Intracranial HypertensionTaiwan
-
QualissimaEuropean UnionCompletedMILD COGNITIVE IMPAIRMENTFrance, Germany, Greece, Italy, Netherlands, Spain
-
Brain Trauma FoundationThe Cleveland Clinic; Weill Medical College of Cornell University; Uniformed... and other collaboratorsNot yet recruitingIntracranial Hypertension | Severe Traumatic Brain InjuryUnited States
-
Alcyone Lifesciences, Inc.CompletedHydrocephalyUnited States
-
Wake Forest University Health SciencesRecruiting
-
Medical University InnsbruckRecruitingSubarachnoid Hemorrhage | Subarachnoid Hemorrhage, Aneurysmal | Aneurysmal Subarachnoid Hemorrhage | Vasospasm, CerebralAustria
-
National Institute of Allergy and Infectious Diseases...Novartis Pharmaceuticals; Autoimmunity Centers of ExcellenceCompletedSecondary Progressive Multiple SclerosisUnited States
-
Centre Hospitalier Universitaire de NīmesCompletedMultiple Sclerosis | Radiologically Isolated SyndromeFrance
-
University of Rome Tor VergataCompletedClinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic LeukemiaAcute Lymphoblastic Leukemia
-
Fondation Ophtalmologique Adolphe de RothschildRecruitingTuberous Sclerosis | Focal Cortical Dysplasia | Hemimegalencephaly | Refractory Focal Epilepsy | Mild Malformation of Cortical Development With Oligodendroglial Hyperplasia in Epilepsy (MOGHE)France